Novartis Ag NVS
NYSE NVS
$163.71 +1.16 (+0.71%)
At close: Nov 9, 2026 · 4:00 PM EST

Novartis Ag (NVS) Restructuring Costs (2009 - 2018)

Updated

Novartis Ag (NVS) reported Restructuring Costs of -$41 million for Q4 2018, compared with -$30 million a year earlier.

Analysis

Novartis Ag (NVS) Restructuring Costs (2009 - 2018) Analysis & Trends

Over the twelve months ended Dec 31, 2018, Novartis Ag's Restructuring Costs came in at -$165 million; for FY2010, it was -$158 million.

  • By year, Restructuring Costs came in at -$40 million in FY2009.
  • The Q4 2018 figure ranks as the lowest quarterly Restructuring Costs since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 139.96 Bn 111.95 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -41.00 Mn
Dec 31, 2017 -30.00 Mn
Dec 31, 2016 -29.00 Mn
Dec 31, 2013 -65.00 Mn
Dec 31, 2012 -34.00 Mn
Dec 31, 2011 -192.00 Mn
Dec 31, 2010 -158.00 Mn
Dec 31, 2009 -40.00 Mn
API Access

Novartis Ag Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NVS&period=max&api_key=YOUR_API_KEY